Aegis Awarded 10th Patent for Fast Acting Migraine Nasal Spray Treatment
SAN DIEGO, June 22, 2017 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded Korean Patent No. 1719008, providing fast acting formulations for triptans, a class of drugs that are effective in treating migraine headaches …